Novo Nordisk Pharma (Taiwan) Ltd.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease.
Healthcare Asia Pharma Awards 2023 Winner: Novo Nordisk Pharma (Taiwan) Ltd.
Healthcare Asia Pharma Awards 2023 Winner: Novo Nordisk Pharma (Taiwan) Ltd.
Novo Nordisk Pharma (Taiwan) Ltd. wins the ESG Programme of the Year - Taiwan award at the Healthcare Asia Pharma Awards 2023.
Novo Nordisk Pharma Taiwan awarded ESG Program of the Year - Taiwan by the Healthcare Asia Pharma Awards
The company's Corporate Social Responsibility awareness programme aims to give back to local communities and take action for environmental improvement.
Most Read
1. US foreign aid cuts pressure health systems in emerging markets 2. Lourdes Hospital’s BIDA Lourdes Campaign: A commitment to future healthcare professionals 3. Data Security Council of India, HIMSS ink MoU for healthcare cybersecurity 4. Abu Dhabi, Microsoft to develop population health intelligence framework 5. Basic automation can help hospitals improve careResource Center
Read Here
Advertise
Sign Up
Partner Events
Event News
Doctors act on the warning signs before a crisis erupts.
